HER2-NEGATIVE BREAST CARCINOMA
Clinical trials for HER2-NEGATIVE BREAST CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new HER2-NEGATIVE BREAST CARCINOMA trials appear
Sign up with your email to follow new studies for HER2-NEGATIVE BREAST CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New DNA vaccine targets tough breast cancer cells
⭐️ VACCINE ⭐️ OngoingThis early-phase trial tests a DNA vaccine called STEMVAC in 42 people with advanced HER2-negative breast cancer. The vaccine aims to train the immune system to attack cancer stem cells, which are resistant to standard treatments. The study focuses on safety and whether the vacci…
Matched conditions: HER2-NEGATIVE BREAST CARCINOMA
Phase: PHASE1 • Sponsor: University of Washington • Aim: ⭐️ VACCINE ⭐️
Last updated May 12, 2026 13:42 UTC
-
Could a lower dose of tamoxifen be just as good for early breast cancer?
Disease control TerminatedThis study compares low-dose tamoxifen to standard hormone therapy (like aromatase inhibitors) in postmenopausal women with early-stage, hormone-positive, HER2-negative breast cancer. The goal is to see if the lower dose works just as well to prevent cancer from coming back, with…
Matched conditions: HER2-NEGATIVE BREAST CARCINOMA
Phase: PHASE3 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
New combo aims to outsmart resistant breast cancer
Disease control OngoingThis early-phase study tests a drug called berzosertib combined with radiation therapy for people with certain types of breast cancer that no longer respond to chemotherapy. The goal is to find the safest dose and see if the combination can shrink or stabilize tumors better than …
Matched conditions: HER2-NEGATIVE BREAST CARCINOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
Daily radiation may spare breast shape in Low-Risk cancer
Disease control OngoingThis study tests a once-daily radiation schedule over five days for women with low-risk, hormone-sensitive breast cancer. The goal is to see if this shorter treatment keeps the breast looking good while still controlling the cancer. About 48 women aged 40 and older with early-sta…
Matched conditions: HER2-NEGATIVE BREAST CARCINOMA
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 14, 2026 12:03 UTC
-
Texts and talks: a new way to help breast cancer patients stay on track with meds
Symptom relief OngoingThis study tests whether adding text message reminders and/or telephone counseling helps breast cancer patients take their daily hormone therapy pills more consistently. About 1,167 women with early-stage hormone receptor-positive breast cancer will be followed for up to two year…
Matched conditions: HER2-NEGATIVE BREAST CARCINOMA
Phase: PHASE3 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Symptom relief
Last updated May 17, 2026 04:16 UTC
-
Blood test could spot hidden cancer cells after breast cancer surgery
Knowledge-focused TerminatedThis study looks at whether a blood test that finds tiny bits of tumor DNA can help doctors know if early-stage breast cancer patients still have cancer cells after treatment. About 350 people with stage I-III breast cancer will give blood samples and tumor tissue. The goal is to…
Matched conditions: HER2-NEGATIVE BREAST CARCINOMA
Phase: NA • Sponsor: City of Hope Medical Center • Aim: Knowledge-focused
Last updated May 17, 2026 04:17 UTC